fda semaglutide shortage resolved february 21 2025 feb Novo's Wegovy and Ozempic removed from US list, compounders on notice FDA Declares Shortage of Novo – fda semaglutide shortage resolved feb

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said

There is no established link between routine GLP-1 use and a need for enzyme supplementation, although it's worth noting that pancreatitis is a rare adverse effect that can affect enzyme production

This fragmentation in the obesity drug race now a projected $100B+ market could be amplifying broader market volatility as investors reprice winner-take-all assumptions

Useful questions to ask FeelGood before enrollment include: Who stores patient intake and health information

10.3389/fnagi.2022.1032494 Front Aging Neurosci